# Neurocrine Biosciences Inc – FDA Inspection, Jul 18, 2024

Source: https://www.keypedia.com/records/fda_inspections/neurocrine-biosciences-inc/5f403df1-ed51-4ca3-b2ed-f93a3ab8b1d4
Source feed: FDA_Inspections

> FDA inspection 1244087 of Neurocrine Biosciences Inc, July 18, 2024. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 314.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1244087
- Company Name: Neurocrine Biosciences Inc
- Inspection Date: 2024-07-18
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Officers

- [Investigator](https://www.keypedia.com/people/lan-t-tran/ab9c1008-c03f-425f-ac3c-a569d3e5037c)
- [Issuing Officer](https://www.keypedia.com/people/theressa-b-smith/80f0c339-7eac-4c73-b9f6-ecb368738fe6)

Company: https://www.keypedia.com/companies/neurocrine-biosciences-inc/581bbb4d-ebb5-4a84-8d2b-c877c8cc12c4

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c